Ritlecitinib in Patients With Keloids or Those Undergoing Keloidectomy

Abroad (travel likely)RecruitingPHASE2

Conditions

Keloid

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Icahn School of Medicine at Mount Sinai, New York, New York, United States
Contact: Study coordinator (Giselle Singer) · giselle.singer@mssm.edu · 212-241-3288
Contact: Study coordinator (Sharlene Martin) · 212-241-3288
Contact: Principal Investigator (Emma Guttman)

Study leads

Emma Guttman, MD, PhD
Principal Investigator
Icahn School of Medicine at Mount Sinai

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Analyse of Diagnosis Value of Keloid on 68Ga-RGD PET-CT

Keloid

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beijing, China

Evaluation of Clinical, Perceived and Instrumental Efficacy of a Scar Gel in Preventing Hypertrophic Scars

Acceptability Study · Real-use Conditions · Safety and Efficacy

Abroad (travel likely)RecruitingPHASE1, PHASE2

Osasco, Brazil · Osasco, Brazil

Keloid Pathogenesis And Fibroblast Activation Study

Keloids · Fibroblast

Abroad (travel likely)Recruiting

Jinhua, China

Topical Cryotherapy and Keloid/Hypertrophic Scars

Keloid Scars · Hypertrophic Scars

Abroad (travel likely)RecruitingPHASE3

Pittsburgh, United States